Asthma Phenotypes in the Inner City

CompletedOBSERVATIONAL
Enrollment

717

Participants

Timeline

Start Date

August 31, 2011

Primary Completion Date

September 30, 2014

Study Completion Date

September 30, 2014

Conditions
AsthmaRhinitis
Interventions
DRUG

Guidelines-based asthma and rhinitis/rhinosinusitis therapy

All participants receive standardized asthma and rhinitis treatment. Asthma and rhinitis medication regimens were based on 1.) the National Asthma Education and Prevention Program (NAEPP) Expert Panel Report -3 (EPR-3) and 2.) the Rhinitis and its Impact on Asthma (ARIA) 2008 guidelines-derived treatment algorithms. References: 1.) J Allergy Clin Immunol 2007; Volume 120, Issue 5, Supplement s93-140. 2.) Allergy 2008; Volume 63, Issue Supplement s86, pages 7-160.

Trial Locations (9)

10032

Columbia University Medical Center, New York

20010

Children's National Medical Center, Washington D.C.

21287

Johns Hopkins University, Baltimore

45202

Cincinnati Children's Hospital, Cincinnati

48202

Henry Ford Health Center, Detroit

60614

Children's Memorial Hospital, Chicago

75390

University of Texas Southwestern Medical School, Dallas

80206

National Jewish Health, Denver

02118

Boston University School of Medicine, Boston

All Listed Sponsors
collaborator

Inner-City Asthma Consortium

NETWORK

lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

NCT01383941 - Asthma Phenotypes in the Inner City | Biotech Hunter | Biotech Hunter